Hva er åpningstidene?

Mandag 09:00 - 17:00 Tirsdag 09:00 - 17:00 Onsdag 09:00 - 17:00 Torsdag 09:00 - 17:00 Fredag 09:00 - 17:00

BulbiTech

Hjem
Norge
Trondheim
BulbiTech

Improving diagnostics with eye tracking

19/06/2025

👁️Bulbitech is Heading to Practical Neuro-Ophthalmology 2025 in Zurich🧠

Are you a neuro-ophthalmologist, orthoptist, or neuro-optometrist working to bridge the gap between neurology and ophthalmology and interested in conducting research on our eye-tracking solution?

We’re excited to announce that Bulbitech will be exhibiting as a Silver Sponsor at the Practical Neuro-Ophthalmology 2025, at Schloss Au in Switzerland. (Interdisciplinary Center for Vertigo and Neurological Visual Disorders - Sponsors)

📍 Where: Schloss Au, Switzerland
📅 When: July 4-5, 2025

Let’s connect, collaborate, and innovate together!

08/05/2025

❗ We are thrilled to share that Solveig Jacobsen Dalbro has reached a major milestone with her first publication using BulbiCAM in Frontiers in Neurology!

👩‍🎓 Her study, “Repeatability, reliability, and stability of eye movement measurements in Parkinson’s disease, cerebellar ataxia, and healthy adults,” explores the precision and consistency of eye movement assessments across different neurological conditions.

👁️ Our Fixation test, Pro Saccade, Smooth Pursuit, and Saccade Analysis were all used in this research. Her work sets the stage for upcoming cross-sectional and longitudinal studies we’re excited about.
Read the full article here: https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1556314/full

🎉 Congratulations to Solveig and the entire research team on this exciting achievement! Their contribution to the field of neurological assessment is both valuable and inspiring.

10/01/2025

Greatful for our demonstration at Kokilaben Dhirubhai Ambani Hospital 🙏

10/01/2025

🇮🇳 Our product launch in India begins!

✈️ Our CCO, Dennis Hens, and Clinical Advisor Ophthalmology, Souhad Lawand MD, PhD Ophthalmology, are hitting the road to showcase our latest product in Delhi, Hyderabad, Chennai, Mumbai, Pune, and Coimbatore.

🤝 Along the way, we'll reconnect with Sankara Nethralaya and visit Renovate Biologicals Pvt Ltd headquarters to offer valuable training and strengthen our partnerships. Stay tuned for exciting updates!

19/12/2024

🙏 Bulbitech would like to thank everyone that has contributed to our progress in 2024. 2025 promises to be an exciting year ahead. Our entire team wishes you a Merry Christmas, magical holiday season and a happy, healthy New Year. 💫

05/12/2024

🇮🇹 Are you attending FLORetina in Florence? Then we’ve got some great news!

❗️our CMO Bjørn André Helland-Hansen and CCO Dennis Hens are showcasing our technology at booth #10

👨‍🎓Bjorn will also present his poster on December 8th. In his clinical trial he found validated biomarkers which are effective in distinguishing early AMD from healthy eyes

07/11/2024

🚀 Exciting news for anyone passionate about advancing ophthalmology! Join Bulbitech at the NHS Research Scotland Ophthalmology and Scottish Eye Research and Innovation Meeting on 22nd November at the Stirling Court Hotel, Scotland.

Our CMO, Dr. Bjørn André Helland-Hansen, will share insights into how Bulbicam’s automated, functional eye examinations are redefining the diagnostic landscape and enhancing clinical workflows, all while enabling more flexible, asynchronous consultations.

This is your chance to interact directly with the Bulbicam system, explore its potential, and engage in discussions on future clinical applications.

🔗 Don’t miss out on this opportunity to witness innovation in action. Join us for a session that blends insight, demonstration, and forward-thinking discussion: https://www.tickettailor.com/events/nhslothian1/1373516

10/10/2024

➡️ How do we validate our medical device and our tests?

This question is asked a lot, so we decided to explain it in two infographics. Since we transition to a Class IIa medical device under MDR each individual clinical parameter/biomarker measured in both healthy controls and patients include the following key statistical components:

1️⃣ Validiity
2️⃣ Reliability
3️⃣ Reproducibility
4️⃣ Stability

❗These components are important as we need to know how a biomarker can be used, which is crucial for regulatory approval and drives further clinical adoption.

PhD candidates Bjørn André Helland-Hansen, Alexander Sverstad & Solveig Jacobsen Dalbro measured these values in healthy controls and patients with the following 👁️ & 🧠 diseases:

👁️ AMD, Glaucoma, Cataract & Diabetic Retinopathy
🧠 Parkinson's Disease & Ataxia

🔜 the PhD candidates will reveal their findings and publish their clinical validation data. So stay tuned!

26/06/2024

📰Norsk oppfinnelse kan revolusjonere øye-diagnostikk - Norwegian invention could revolutionize eye diagnostics

Prof. Goran Petrovski, MD, PhD, Dr habil , Prof. Emilija Kerty and neurologist Solveig Jacobsen Dalbro share their view in Aftenposten on our technology. 👀 more in the link below:

https://lnkd.in/ekXCpbAY

26/06/2024

👍 Proud to be one of the selected companies from Norway in the Nordic Star 2024 pitch competition at the Nordic Life Science Days

03/06/2024

⚡ We're excited to attend the European Neuro-Ophthalmology Society Annual Meeting 2024 in Rotterdam and our booth is ready for you to visit!

👨‍⚕️ is Europe's leading society representing and promoting clinical neuro-ophthalmology. Since its founding in 1993, extends the knowledge of neuro-ophthalmology by fostering cooperation and communication among clinical neuro-ophthalmologists and visual scientists within Europe and beyond.

🧠 👀Neuro-ophthalmologists, like Denize Atan & Jana Preiningerova recognize the potential of eye tracking in clinical practices as we offer quantifiable results to make diagnostics easier for patients with Parkinson's, Ataxia, MS, AMD, Glaucoma, Thyroid's Eye Disease, Nystagmus & many other indications.

🤝 Bulbitech's solution is fully CE-certified, already in use at 20+ clinics and we are presenting our clinical validation results in patients with Parkinson's, Ataxia, AMD & Thyroid's Eye Disease. Interested in how we can contribute to your clinic? Visit booth 8 and meet Area Sales Manager Atsuko Ikeda Steinnes & CEO Dennis Hens to learn how our technology can improve your clinical workflow.

21/05/2024

🗓 The 16th bi-annual meeting is coming and will take place on 3-6 June 2024 in De Doelen, Rotterdam, The Netherlands!

⚡ Bulbitech is excited to be a silver sponsor for this three-day event that features four captivating symposia: Diagnostics (Day 1), Artificial Intelligence (Day 2), Trials (Day 2) and New Medication (Day 3). Led by esteemed experts in the field, these symposia will delve into the latest breakthroughs and advancements in neuro-ophthalmology.

🙏 Thanks to the organizers and the lecturers for sharing their expertise and knowledge! More info can be read here: https://eunos2024.org/our-sponsors/

Bulbitech utilizes neuro-ophthalmic biomarkers in patients with eye and brain diseases to diagnose more precisely, reduce examination time, and save healthcare costs. Bulbitech offers neurologists and ophthalmologists 14 eye-tracking-based tests to reduce the time of the neuro-ophthalmic exam. At Bulbitech we know eye movements and pupillary responses contain a treasure of health and disease data.

Do not hesitate to contact CEO Dennis Hens & Area Sales Manager Atsuko Ikeda Steinnes in Rotterdam. They can be visited at stand 8.

Adresse

Dybdahls Veg 3-5
Trondheim
7051

Åpningstider

Mandag	09:00 - 17:00
Tirsdag	09:00 - 17:00
Onsdag	09:00 - 17:00
Torsdag	09:00 - 17:00
Fredag	09:00 - 17:00

Nettsted

https://www.bulbitech.com/

Varslinger

Vær den første som vet og la oss sende deg en e-post når BulbiTech legger inn nyheter og kampanjer. Din e-postadresse vil ikke bli brukt til noe annet formål, og du kan når som helst melde deg av.

Kontakt Praksisen

Send en melding til BulbiTech:

Snarveier

Vil du plassere din praksis på toppen av Klinikk-listen i Trondheim?

Del

Type

Leverandør av medisinsk utstyr